We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Awards highlights include: cyber security, deal making and the most innovative law firms and individuals
Featuring examples of the most innovative services that lawyers have developed for clients
Case studies showcase how law firms are innovating as businesses
The lawyers profiled here have all had an impact during a period of drastic development
The top 10 individuals featured below have looked beyond their specialisms to solve client demands
The country increasingly represents the safest choice for a regional hub
Awards highlights include: digitisation, enabling business, and the most innovative law firms and individuals
Investment in employee health and wellbeing contribute to strategies for growth
Firms add wellbeing schemes on top of escalating payouts to combat employee attrition
Crypto collaboration followed lobbying in the US to deliver a lifeline for those on the frontline
Ten lawyers highlighted for expertise in solving clients’ problems
A new, tech-based breed of fund promises potential big savings for clients
US counterparts’ vaccination requirement for employees increases dilemma over risk of discrimination
Three lawyers took different career paths to work where environment and law intersect
The enabling deals behind self-driving cars, fundraising for start-ups, and an energy transaction
Tony West will have to deal with litigation and regulatory action on multiple fronts
Corporate lawyers are applying their know-how to help non-profit organisations raise funds
The overall winner personifies the multidisciplinary professional that clients say they need
Firms can play an increasingly central role in unlocking investment for projects to materialise
A practice focused on sustainability earns a partner the top award
Market leader rejects accusations of exposing amateur investors to risks they may not appreciate
Big pharma groups pay higher charges for access to most promising molecules
International Edition
